Cardiology - Original Articles
June 7, 2018
Vol. 88 No. 2 (2018)
Cognitive impairment in patients with atrial fibrillation: What is the importance of anticoagulant therapy?
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
3022
Views
558
Downloads
Authors
Atrial fibrillation represents one of the most significant aging markers and its prevalence increases with age, reaching 11.1% in men and 9.1% in women aged over 85 years. Fragility is nowadays defined according to two different phenotypes: the biologic-physiologic phenotype developed by L. Fried and Baltimora School and the clinic-multidimensional phenotype, proposed by Rockwood and Halifax School. If the clinical characteristics of elder patients hospitalized in acute geriatric unit care are considered, differences appear in the clinical features, in co-morbidity, in therapy and prognosis.
Altmetrics
Downloads
Download data is not yet available.
Citations
How to Cite
“Cognitive Impairment in Patients With Atrial Fibrillation: What Is the Importance of Anticoagulant Therapy?”. 2018. Monaldi Archives for Chest Disease 88 (2). https://doi.org/10.4081/monaldi.2018.956.